Latest Aragen Life Sciences News | Aragen Life Sciences News | Aragen Life Sciences Funding | Aragen Life Sciences Fund - vccircle
Advertisement

Aragen Life Sciences

Avendus PE fund, SBI Life bet on Aragen Life Sciences

Healthcare

13 August, 2025

Avendus PE fund, SBI Life bet on Aragen Life Sciences

The Avendus Future Leaders Fund, a private equity vehicle managed by Mumbai-based investment bank and asset manager Avendus Group, and ......

Quadria bets $100 mn on IPO-bound contract drugs manufacturer Aragen

Healthcare

13 January, 2025

Quadria bets $100 mn on IPO-bound contract drugs manufacturer Aragen

Healthcare-focused private equity firm Quadria Capital is investing $100 million (about Rs 860 crore) in Hyderabad-based contract drug development and ......

Premium
Grapevine: TVS Credit, Avendus, Haldiram, Aragen, Yotta in news

General

19 December, 2024

Grapevine: TVS Credit, Avendus, Haldiram, Aragen, Yotta in news

Another investor has joined the race to buy KKR's stake in Avendus, while a top US-based private equity firm is ......

Premium
Goldman Sachs-backed Aragen Life Sciences weighs IPO, in talks with bankers

Healthcare

17 December, 2024

Goldman Sachs-backed Aragen Life Sciences weighs IPO, in talks with bankers

Aragen Life Sciences Ltd, a contract drug development and manufacturing company backed by private equity funds managed by Goldman Sachs, ......

Premium
Grapevine: Aragen Life, Urban Company investors weigh stake sale

General

18 September, 2024

Grapevine: Aragen Life, Urban Company investors weigh stake sale

Promoters and investors in Aragen Life Sciences, the Goldman Sachs-backed contract research organisation (CRO), plan to sell a 10% stake in a ......

Premium
Zydus promoters eye $200 mn from sale of private clinical research biz

Finance

04 May, 2023

Zydus promoters eye $200 mn from sale of private clinical research biz

Zydus Group is exploring the sale of its clinical research business, Cliantha Research Ltd, in a deal that could potentially ......

Goldman Sachs invests in Aragen Life Sciences; ChrysCap exits

Healthcare

19 May, 2021

Goldman Sachs invests in Aragen Life Sciences; ChrysCap exits

Goldman Sachs has picked up a significant minority stake in contract research organisation Aragen Life Sciences.  This has paved the way ......

Advertisement

Most Popular

Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News